Rather than seeking a single cure — a magic bullet — for Alzheimer’s disease, a shotgun blast of different drugs with different targets may be a better approach to this very complex condition.

Northwestern researchers made progress on new biochemical possibilities this week, in both the human brain and everyday farming soil. The Daily compiled a recap of these developments. Using the immune system to stop the “amyloid cascade” of Alzheimer’s Researchers at NU’s Feinberg School of Medicine recently discovered how different genes affect amyloid beta treatments

"Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks," Achrekar said. "It is the most common cause of dementia among older adults." Diagnoses of the memory-loss disease normally happens after the age of 60.

Dr. Solomon Carter Fuller was the first Black psychiatrist and neurologist in the United States but has long been overlooked.

Researchers analyzed the brain of a woman with down syndrome and Alzheimer’s disease, and were shocked to discover that despite having all the “brain changes” of the disease, her cognitive functioning remained “intact.

Poor retinal health in midlife is associated with increased risk for Alzheimer’s disease and related dementias later on, suggesting retinal imaging as a tool for dementia screening.